Pay in 4 interest-free payments of $5.32 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Current research reveals several critical limitations: insufficient investigation into the material basis of Mongolian drugs, a lack of systematic pharmacological studies, unclear pharmacokinetic properties, ambiguous compatibility principles in formulation, and slow progress in the development of new Mongolian medicines (Song et al., 2021)
doi:10.5935/1518-0557.20180046
(1995): A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY100635
Canadian users benefit from domestic suppliers who understand local needs and provide reliable products with appropriate testing documentation
Oral spray, sublingual, and nasal delivery are increasingly viable alternatives for compliance and patient-preference reasons
US$ 24.51
US$ 23.95
US$ 21.52
US$ 25.86
US$ 28.27
